FundingWatcher
Home / Startups / Top health care startups / Health care startups that raised Series A / Health care startups that raised Series A in Massachusetts, United States

Health care startups that raised Series A in Massachusetts, United States

Updated 16 Nov 2026

Reset
Health care startups that raised Series A in Massachusetts, United States
One-time CSV
  • 308 funded companies, 267 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care--series-a~massachusetts-united-states.csv308 rows × 18 columns
CompanyCityLast roundAmountDate
Remedium BioNeedhamSeries A$10.0M2026-08-10
Dash BioBostonSeries A$30.0M2026-08-03
InStockRxBostonSeries A$5.0M2026-07-01
Xellar BiosystemsNewtonSeries A$29.5M2026-06-30
EnVision EndoscopyLowellSeries A$500K2026-03-30
Coral CareBostonSeries A$13.0M2026-02-23
Third Arc BioBostonSeries A$52.0M2026-02-04
AI ProteinsBostonSeries A$42.5M2025-11-19

8 rows of the CSV in 5 of its 18 columns.

308
Startups
$12.3B
Total raised
31
Funded in the last 12 months
$1.2B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 308
30 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Remedium Bio Remedium Bio develops gene therapy treatments for various diseases. Biotech Needham Series A $10.0M 2026-08-10 $13.8M National Science Foundation, MicroVentures, Longevitytech.fund +1 11 to 50 2020
Dash Bio Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. Artificial intelligence Boston Series A $30.0M 2026-08-03 $47.5M Freestyle Capital, Swift Ventures, LifeX Ventures +1 11 to 50 2024
InStockRx InStockRx connects licensed pharmacies to buy and sell inventory with each other. Commerce Boston Series A $5.0M 2026-07-01 $5.1M Techstars 1 to 10 2020
Xellar Biosystems Xellar Biosystems analyzes drug testing and treatment data using artificial intelligence. Artificial intelligence Newton Series A $29.5M 2026-06-30 $93.2M Legend Capital, Tiantu Capital, Zhengxuan Investment +1 11 to 50 2022
EnVision Endoscopy EnVision Endoscopy supplies medical devices and solutions used in endoscopic surgeries. Health care Lowell Series A $500K 2026-03-30 $3.9M MassChallenge, National Science Foundation, MassVentures +1 1 to 10 2018
Coral Care Coral Care connects families with licensed speech, occupational, and physical therapists through a pediatric therapy platform. Health care Boston Series A $13.0M 2026-02-23 $19.5M Hustle Fund, Reach Capital, AlleyCorp +2 11 to 50 2023
Third Arc Bio Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. Biotech Boston Series A $52.0M 2026-02-04 $217.0M T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 11 to 50 2022
AI Proteins AI Proteins designs and engineers miniprotein therapeutics using artificial intelligence. Artificial intelligence Boston Series A $42.5M 2025-11-19 $80.4M Intel Ignite, Lightchain Capital, Cobro Ventures 11 to 50 2021
FamilyWell Health FamilyWell Health provides integrated mental health services for pregnant and postpartum patients. Health care Boston Series A $8.0M 2025-11-18 $13.3M .406 Ventures, GreyMatter, Springboard Enterprises +1 11 to 50 2022
Folia Health Folia Health is a platform that securely captures and shares users' health and symptom data. Biotech Boston Series A $10.5M 2025-10-01 $17.4M MassChallenge, Social Starts, Bantam Group +2 11 to 50 2016
Eyebot Eyebot develops eye examination technology to expand access to quality vision care. Artificial intelligence Boston Series A $20.0M 2025-08-26 $29.9M National Science Foundation, Village Global, MassVentures +2 11 to 50 2021
Biobot Analytics Biobot Analytics offers a wastewater data platform that delivers population-level health insights. Artificial intelligence Cambridge Series A $13.4M 2025-06-06 $41.4M Y Combinator, Pioneer Fund, Soma Capital +2 11 to 50 2017
PhaseV PhaseV provides AI-driven solutions for clinical development and operations. Artificial intelligence Boston Series A $50.0M 2025-05-13 $65.0M Viola Ventures, LionBird, GETTY +1 11 to 50 2023
Lynx Lynx provides an API-driven platform that lets businesses integrate healthcare financial services, payments, banking, and investments. Fintech Boston Series A $27.0M 2025-02-06 $44.5M .406 Ventures, Obvious Ventures, Frist Cressey Ventures +2 11 to 50 2021
ZETA SURGICAL ZETA SURGICAL provides real-time frameless navigation for brain surgery, deployable beyond the operating room. Artificial intelligence Boston Series A $5.0M 2025-01-21 $13.9M Y Combinator, Artesian VC, Brinc +2 11 to 50 2018
Convergent Therapeutics Convergent Therapeutics develops radiopharmaceutical therapies for prostate cancer. Health care Cambridge Series A $40.0M 2024-09-24 $130.0M RA Capital Management, OrbiMed, Invus 1 to 10 2021
Axena Health Axena Health develops commercial-stage medical devices for women's pelvic health. Health care Newton Series A $9.4M 2024-06-04 $36.2M KOFA Healthcare, Avestria Ventures, Cross-Border Impact Ventures 11 to 50 2023
Progentos Therapeutics Progentos Therapeutics develops a multiple sclerosis treatment that stimulates the body's natural repair mechanisms. Biotech Watertown Series A $65.0M 2024-05-14 $65.0M Forbion Capital Partners, Dolby Family Ventures, Alta Partners +2 11 to 50 2023
Nabla Bio Nabla Bio uses an autoverse platform of biologically informed machine learning to co-develop antibody drugs. Artificial intelligence Cambridge Series A $26.0M 2024-05-14 $37.4M Y Combinator, Khosla Ventures, National Science Foundation +2 11 to 50 2020
MeaCor MeaCor develops transcatheter devices for treating heart disease. Health care Ayer Series A $15.0M 2024-05-14 $15.0M MedTech Innovator 1 to 10 2015
Opmed.ai Opmed.ai provides technologies and services for hospitals and healthcare providers. Health care Boston Series A $15.0M 2024-05-06 $15.0M NFX, Grove Ventures, Secret Chord Ventures +1 11 to 50 2020
Delphia Therapeutics Delphia Therapeutics operates a laboratory that develops treatments for cancer cells. Health care Cambridge Series A $67.0M 2024-05-02 $67.0M Google Ventures, Polaris Partners, Alexandria Venture Investments +1 11 to 50 2022
Adaptilens Adaptilens develops an accommodating intraocular lens for cataract patients. Biotech Boston Series A $17.5M 2024-04-29 $19.1M MassChallenge, Pillar VC, Perceptive Advisors +2 1 to 10 2019
Corner Therapeutics Corner Therapeutics conducts biotechnology research focused on immunotherapy. Biotech Watertown Series A $58.5M 2024-04-18 $58.5M Bill & Melinda Gates Foundation, Ziff Capital Partners, Tanis ventures 11 to 50 2020
ZWI Therapeutics, Inc. ZWI Therapeutics develops a polymer that reduces immunogenicity and improves protein therapeutic pharmacokinetics. Health care Watertown Series A $10.0M 2024-01-24 $20.0M Sherpa Healthcare Partners 1 to 10 2020
Tome Biosciences Tome Biosciences develops programmable gene insertion technology. Biotech Watertown Series A $213.0M 2023-12-12 $213.0M Andreessen Horowitz, Google Ventures, Polaris Partners +1 101 to 250 2021
Ascidian Therapeutics Ascidian Therapeutics is a biotechnology company focused on medical and clinical gene therapy. Biotech Boston Series A $40.0M 2023-11-08 $90.0M Apple Tree Partners 11 to 50 2020
ClinOne ClinOne provides a clinical trial management solution with web and mobile access to trial details. Health care Needham Series A $2.0M 2023-11-01 $10.5M Social Starts, Stout Street Capital, Rockies Venture Club +2 11 to 50 2013
i2o Therapeutics I2o Therapeutics is a biotech company that develops safe, effective oral formulations of therapies. Biotech Allston Series A $46.0M 2023-08-28 $90.4M Cerity Partners Ventures, Viva BioInnovator, Sanofi Ventures +1 11 to 50 2019
Luminopia Luminopia develops digital treatments for significant neuro-visual disorders. Biotech Cambridge Series A $16.0M 2023-06-27 $33.1M MassChallenge, U.S. Venture Partners, Bantam Group +2 11 to 50 2015

Table 1. Health care startups that raised Series A in Massachusetts, United States: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 308.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Third Arc Bio Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. Biotech Boston Series A $52.0M 2026-02-04 $217.0M T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 11 to 50 2022
2 AI Proteins AI Proteins designs and engineers miniprotein therapeutics using artificial intelligence. Artificial intelligence Boston Series A $42.5M 2025-11-19 $80.4M Intel Ignite, Lightchain Capital, Cobro Ventures 11 to 50 2021
3 Dash Bio Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. Artificial intelligence Boston Series A $30.0M 2026-08-03 $47.5M Freestyle Capital, Swift Ventures, LifeX Ventures +1 11 to 50 2024
4 Xellar Biosystems Xellar Biosystems analyzes drug testing and treatment data using artificial intelligence. Artificial intelligence Newton Series A $29.5M 2026-06-30 $93.2M Legend Capital, Tiantu Capital, Zhengxuan Investment +1 11 to 50 2022
5 Coral Care Coral Care connects families with licensed speech, occupational, and physical therapists through a pediatric therapy platform. Health care Boston Series A $13.0M 2026-02-23 $19.5M Hustle Fund, Reach Capital, AlleyCorp +2 11 to 50 2023
6 Remedium Bio Remedium Bio develops gene therapy treatments for various diseases. Biotech Needham Series A $10.0M 2026-08-10 $13.8M National Science Foundation, MicroVentures, Longevitytech.fund +1 11 to 50 2020
7 FamilyWell Health FamilyWell Health provides integrated mental health services for pregnant and postpartum patients. Health care Boston Series A $8.0M 2025-11-18 $13.3M .406 Ventures, GreyMatter, Springboard Enterprises +1 11 to 50 2022
8 InStockRx InStockRx connects licensed pharmacies to buy and sell inventory with each other. Commerce Boston Series A $5.0M 2026-07-01 $5.1M Techstars 1 to 10 2020
9 EnVision Endoscopy EnVision Endoscopy supplies medical devices and solutions used in endoscopic surgeries. Health care Lowell Series A $500K 2026-03-30 $3.9M MassChallenge, National Science Foundation, MassVentures +1 1 to 10 2018

Table 2. Health care startups that raised Series A in Massachusetts, United States: the 9 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 MassChallenge Startup accelerator Boston, United States 9 3% 1 EnVision Endoscopy
2 National Science Foundation Entrepreneurship program Alexandria, United States 5 2% 2 Remedium Bio, EnVision Endoscopy
3 Y Combinator Startup accelerator Mountain View, United States 5 2%
4 MassVentures Venture capital firm Boston, United States 4 1% 1 EnVision Endoscopy
5 .406 Ventures Venture capital firm Boston, United States 4 1% 1 FamilyWell Health
6 Social Starts Micro VC fund San Francisco, United States 4 1%
7 Google Ventures Corporate venture arm San Francisco, United States 4 1%
8 Polaris Partners Private equity firm Boston, United States 4 1%
9 Alumni Ventures Angel group Manchester, United States 4 1%
10 Techstars Startup accelerator New York, United States 3 1% 1 InStockRx
11 Invus Private equity firm New York, United States 3 1%
12 Alexandria Venture Investments Venture capital firm Pasadena, United States 3 1%
13 AlleyCorp Startup incubator New York, United States 2 1% 1 Coral Care
14 GreyMatter Venture capital firm New York, United States 2 1% 2 Coral Care, FamilyWell Health
15 Foresite Capital Private equity firm San Francisco, United States 2 1% 1 Third Arc Bio

Table 3. Health care startups that raised Series A in Massachusetts, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 196 64% $10.1B
Software 64 21% $1.5B
Artificial intelligence 34 11% $945.7M
Hardware 21 7% $329.1M
Commerce 7 2% $45.6M
Fintech 7 2% $107.3M
Education 5 2% $33.7M
Cybersecurity 1 0% $3.2M
Energy 1 0%

Table 4. Health care startups that raised Series A in Massachusetts, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series A 308 100% $20.0M

Table 5. Health care startups that raised Series A in Massachusetts, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Cambridge 106 34%
Boston 97 31%
Lexington 11 4%
Watertown 10 3%
Newton 7 2%
Natick 7 2%
Waltham 7 2%
Woburn 6 2%
Allston 4 1%
Somerville 4 1%
Burlington 4 1%
Beverly 3 1%

Table 6. Health care startups that raised Series A in Massachusetts, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 3% $11.5M
October 2026 1 3% $30.0M
September 2026 4 13% $307.3M
August 2026 3 10% $70.0M
July 2026 3 10% $44.0M
June 2026 3 10% $59.1M
April 2026 3 10% $209.0M
March 2026 3 10% $59.5M
February 2026 2 6% $65.0M
January 2026 4 13% $167.5M
December 2025 1 3% $47.5M
November 2025 3 10% $140.5M

Table 7. Health care startups that raised Series A in Massachusetts, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 27 9% $1.0B
2025 36 12% $1.6B
2024 25 8% $1.1B
2023 27 9% $1.4B
2022 33 11% $1.0B
2021 37 12% $1.2B

Table 8. Health care startups that raised Series A in Massachusetts, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 27 9%
2020 to 2022 83 27%
2015 to 2019 101 33%
2010 to 2014 55 18%
Before 2010 39 13%

Table 9. Health care startups that raised Series A in Massachusetts, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 93 30%
11 to 50 176 58%
51 to 100 19 6%
101 to 250 13 4%
251 to 500 2 1%
501 to 1,000 2 1%
10,001 or more 1 0%

Table 10. Health care startups that raised Series A in Massachusetts, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Massachusetts, United States whose last round is Series A are on the list?
308, in the file dated 16 November 2026. 31 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 308 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups that raised Series A in Massachusetts, United States: 308 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care at other stages in Massachusetts

Other sectors that raised Series A in Massachusetts

Cite: FundingWatcher, 308 health care companies in Massachusetts, United States whose most recent round is Series A, 16 November 2026. https://fundingwatcher.com/startups/health-care/series-a/massachusetts-united-states/